DRDO Developed '2-DG' Drug Inhibits Coronavirus Multiplication, Likely To Work Against All COVID Variants: StudyIANSJun 15, 2021 01:57 PM +05:30 IST
DRDO To Transfer Technology Of Anti-COVID Drug '2-DG' To India Pharma Firms, Invites EoISwarajya StaffJun 9, 2021 12:55 PM +05:30 IST
Reliance Submits Proposal For Use Of Niclosamide As Potential COVID-19 DrugIANSJun 3, 2021 09:19 AM +05:30 IST
DRDO’s 2-DG: Anti-Covid Drug Approved By DCGI Was First Studied By Patanjali Researchers Bhaswati Guha Majumder May 10, 2021 10:58 AM +05:30 IST
Once Given To Trump, This Antibody Drug Cocktail Receives Emergency Approval To Treat Covid-19 In IndiaBhaswati Guha Majumder May 8, 2021 05:00 PM +05:30 IST